1 report

The pre-clinical study showed the blocking of c-Rel activity in mice ameliorates allergic asthma, multiple sclerosis, type I diabetes, and arthritis.

  • Heart Transplant
  • Pharmaceutical
  • United States
  • World
  • Viron Therapeutics Inc.